Yuichi Imai

1PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 01, 2025
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial.

Shin Nishio, Tadaaki Nishikawa, Masahiko Mori

Pageof 1

Frequent Collaborators

1 joint publications

Shin Nishio

1 joint publications

Tadaaki Nishikawa

1 joint publications

Masahiko Mori

1 joint publications

Shoji Kamiura